Schizophrenia Research Forum - A Catalyst for Creative Thinking


Gelfand EV, Cannon CP. Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors. J Am Coll Cardiol. 2006 May 16 ; 47(10):1919-26. Pubmed Abstract